Adjunctive use of Angio-Seal closure device following transcatheter aortic valve implantation via percutaneous transfemoral approach with incomplete hemostasis after modified Perclose ProGlide preclosure technique
نویسندگان
چکیده
منابع مشابه
CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach.
O o the Editor: Transcatheter aortic valve implantation (TAVI) has merged as a promising alternative to surgical aortic valve replaceent for patients with severe aortic stenosis considered to be at igh operative risk. TAVI is most commonly performed via the emoral artery. However, the large-diameter delivery catheters of oth the Edwards Sapien (Edwards Lifesciences, Irvine, Califoria) and Medtr...
متن کاملecg abnormalities after transcatheter aortic valve implantation
transcatheteraortic valve implantation, first introduced in 2002, has been established as an alternative modality for patients deemed not suitable for open-heart surgery. the anatomical vicinity of the atrioventricular node and the his bundle to the non-coronary and rightcoronary aortic cusps predisposes patients to conduction abnormalities in case of severe calcification or mechanical trauma d...
متن کاملPercutaneous closure of paravalvular leak after transcatheter aortic valve replacement.
An 86-year-old male underwent TAVR with a 26 mm Sapien valve, co valve, moderate-to-severe paravalvular AI persisted. The patient quick catheter was advanced across the tract over a stiff angled glidewire; a reduction of AI and rapid clinical recovery. (A) TEE long-axis and (B) shor confirms the 4-F MP catheter has been advanced outside the struts of th resulting in substantial reduction of AI ...
متن کاملOutcomes after transfemoral transcatheter aortic valve replacement.
Fro Pre kE #H & W kkC on en Va rec Ex an 2 t OBJECTIVES This study sought to determine whether outcomes for transfemoral (TF) transcatheter aortic valve replacement (TAVR) differ between the randomized controlled trial (RCT) and the subsequent NRCA (Nonrandomized Continued Access) registry of the PARTNER (Placement of AoRTic TraNscathetER Valves) trial. BACKGROUND The PARTNER RCT demonstrated t...
متن کاملTotally Percutaneous Access Using Perclose Proglide for Endovascular Treatment of Aortic Diseases
Objective To evaluate our experience following the introduction of a percutaneous program for endovascular treatment of aortic diseases using Perclose Proglide® assessing efficacy, complications and identification of potential risk factors that could predict failure or major access site complications. Methods A retrospective cohort study during a two-year period was performed. All the patient...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Baylor University Medical Center Proceedings
سال: 2019
ISSN: 0899-8280,1525-3252
DOI: 10.1080/08998280.2018.1524102